feed,title,long_url,short_url
Benzinga,Rubius Therapeutics to Participate in 7th Annual Jefferies Cell Therapy Summit,https://www.benzinga.com/pressreleases/20/09/g17705930/rubius-therapeutics-to-participate-in-7th-annual-jefferies-cell-therapy-summit,https://j.mp/34amoOf
Benzinga,Galapagos announces first dosing with Toledo compound GLPG3970 in psoriasis trial,https://www.benzinga.com/pressreleases/20/09/g17705920/galapagos-announces-first-dosing-with-toledo-compound-glpg3970-in-psoriasis-trial,https://j.mp/30ixTSM
Benzinga,"Cytovia Therapeutics to present at Jefferies Cell Therapy Virtual Summit, BIO Investor Forum and New York Stem Cell Foundation Conference in October 2020",https://www.benzinga.com/pressreleases/20/09/g17705902/cytovia-therapeutics-to-present-at-jefferies-cell-therapy-virtual-summit-bio-investor-forum-and-ne,https://j.mp/2Glaqcx
Benzinga,Jiayin Group Inc. Announces Closing of the Acquisition of 35% Equity Interest in Keen Best Investments Limited,https://www.benzinga.com/pressreleases/20/09/g17705901/jiayin-group-inc-announces-closing-of-the-acquisition-of-35-equity-interest-in-keen-best-investmen,https://j.mp/3jihVPV
